Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Genes (Basel). 2020 Aug 25;11(9):989. doi: 10.3390/genes11090989.
The mammalian target of rapamycin (mTOR) is an evolutionary conserved Ser/Thr protein kinase that senses multiple upstream stimuli to control cell growth, metabolism, and autophagy. mTOR is the catalytic subunit of mTOR complex 1 (mTORC1). A significant amount of research has uncovered the signaling pathways regulated by mTORC1, and the involvement of these signaling cascades in human diseases like cancer, diabetes, and ageing. Here, we review advances in mTORC1 regulation by upstream stimuli. We specifically focus on how growth factors, amino acids, G-protein coupled receptors (GPCRs), phosphorylation, and small GTPases regulate mTORC1 activity and signaling.
哺乳动物雷帕霉素靶蛋白(mTOR)是一种进化上保守的丝氨酸/苏氨酸蛋白激酶,它可以感知多种上游刺激来控制细胞生长、代谢和自噬。mTOR 是 mTOR 复合物 1(mTORC1)的催化亚基。大量的研究已经揭示了 mTORC1 调节的信号通路,这些信号级联在人类疾病如癌症、糖尿病和衰老中的作用。在这里,我们回顾了上游刺激对 mTORC1 调节的进展。我们特别关注生长因子、氨基酸、G 蛋白偶联受体(GPCRs)、磷酸化和小 GTP 酶如何调节 mTORC1 的活性和信号转导。